“GlySure Limited today announced that it has secured the CE Mark for the world’s first and only Continuous Intravascular Glucose Monitoring System (CIGMS). The initial use of the GlySure™ CIGMS is to enhance blood glucose management among adult cardiac surgery patients in the Intensive Care Un
“GlySure Limited today announced that it has secured the CE Mark for the world’s first and only Continuous Intravascular Glucose Monitoring System (CIGMS). The initial use of the GlySure™ CIGMS is to enhance blood glucose management among adult cardiac surgery patients in the Intensive Care Un
このブックマークにはスターがありません。
最初のスターをつけてみよう！
GlySure Secures CE Mark and Launches World’s First Continuous Intravascular Glucose Monitoring System
1 人がブックマーク・1 件のコメント
＼ コメントが サクサク読める アプリです ／